Correlation Between Enlivex Therapeutics and Knowles Cor

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Enlivex Therapeutics and Knowles Cor at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enlivex Therapeutics and Knowles Cor into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enlivex Therapeutics and Knowles Cor, you can compare the effects of market volatilities on Enlivex Therapeutics and Knowles Cor and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enlivex Therapeutics with a short position of Knowles Cor. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enlivex Therapeutics and Knowles Cor.

Diversification Opportunities for Enlivex Therapeutics and Knowles Cor

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between Enlivex and Knowles is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Enlivex Therapeutics and Knowles Cor in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Knowles Cor and Enlivex Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enlivex Therapeutics are associated (or correlated) with Knowles Cor. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Knowles Cor has no effect on the direction of Enlivex Therapeutics i.e., Enlivex Therapeutics and Knowles Cor go up and down completely randomly.

Pair Corralation between Enlivex Therapeutics and Knowles Cor

Given the investment horizon of 90 days Enlivex Therapeutics is expected to under-perform the Knowles Cor. In addition to that, Enlivex Therapeutics is 2.39 times more volatile than Knowles Cor. It trades about -0.24 of its total potential returns per unit of risk. Knowles Cor is currently generating about 0.1 per unit of volatility. If you would invest  1,809  in Knowles Cor on August 27, 2024 and sell it today you would earn a total of  84.00  from holding Knowles Cor or generate 4.64% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Enlivex Therapeutics  vs.  Knowles Cor

 Performance 
       Timeline  
Enlivex Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Enlivex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Knowles Cor 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Knowles Cor are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Knowles Cor is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Enlivex Therapeutics and Knowles Cor Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Enlivex Therapeutics and Knowles Cor

The main advantage of trading using opposite Enlivex Therapeutics and Knowles Cor positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enlivex Therapeutics position performs unexpectedly, Knowles Cor can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Knowles Cor will offset losses from the drop in Knowles Cor's long position.
The idea behind Enlivex Therapeutics and Knowles Cor pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas